Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,242 | 14,034 | 56,566 | 2,426 | 7,775 |
| Marketable Securities | 20,084 | 30,023 | N/A | N/A | N/A |
| Receivables | 225 | 193 | N/A | N/A | 364 |
| TOTAL | $39,581 | $46,951 | $58,907 | $3,128 | $9,006 |
| Non-Current Assets | |||||
| PPE Net | 16,922 | 17,903 | 19,737 | 20,622 | 21,528 |
| Investments And Advances | 0 | 1,235 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,390 | 5,282 | 5,298 | 4,587 | 4,909 |
| TOTAL | $22,311 | $24,420 | $25,034 | $25,209 | $26,436 |
| Total Assets | $61,892 | $71,371 | $83,941 | $28,336 | $35,443 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,171 | 1,240 | 946 | 1,083 | 1,404 |
| Accrued Expenses | 5,054 | 5,174 | 6,692 | 5,300 | 5,928 |
| TOTAL | $7,552 | $8,305 | $10,813 | $9,211 | $11,011 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 542 |
| Deferred Revenues | 115 | 378 | 1,322 | 1,627 | 2,895 |
| Other Non-Current Liabilities | 4,872 | 6,861 | 12,410 | 417 | 688 |
| TOTAL | $8,220 | $10,244 | $15,829 | $3,870 | $4,715 |
| Total Liabilities | $15,772 | $18,549 | $26,642 | $13,081 | $15,726 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,229 | 9,229 | 9,225 | 5,232 | 5,232 |
| Common Shares | 1 | 1 | 1 | 5 | 5 |
| Retained earnings | -102,425 | -95,089 | -90,064 | -67,207 | -62,105 |
| Other shareholders' equity | 447 | 415 | 505 | 479 | 479 |
| TOTAL | $46,120 | $52,822 | $57,299 | $15,256 | $19,717 |
| Total Liabilities And Equity | $61,892 | $71,371 | $83,941 | $28,336 | $35,443 |